Více o knize
This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.
Nákup knihy
Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry, Charles Ralph Buncher, Jia-Yeong Tsay
- Jazyk
- Rok vydání
- 1993
- product-detail.submit-box.info.binding
- (pevná),
- Stav knihy
- Poškozená
- Cena
- 153 Kč
Doručení
Platební metody
Nikdo zatím neohodnotil.
- Titul
- Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry
- Podtitul
- 3rd Edition
- Jazyk
- anglicky
- Vydavatel
- CRC Press
- Rok vydání
- 1993
- Vazba
- pevná
- Počet stran
- 592
- ISBN10
- 0824790731
- ISBN13
- 9780824790738
- Série
- Štítky
- Naučná literatura, Věda & Matematika, Matematika, USA, Technologie, Lékařská tématika, Drogy, Lékárnictví, farmacie, Léky, léčiva, Epidemiologie
- Anotace
- This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.